Imagine indisponibilăAnti-TRAF1 Antibody [TRAF1/2770]
Pe scurt
Anti-TRAF1 Antibody [TRAF1/2770] este un anticorp monoclonal de șoarece împotriva țintei TRAF1, cu reactivitate declarată pentru Human. Este validat pentru IHC-P, are izotipul IgG1 și se livrează neconjugat. Se livrează în mărimea 100µg, la prețul de 3.826,63 lei cu TVA.
Produse destinate exclusiv cercetării. Nu se utilizează în diagnostic sau tratament.
Descriere
Mouse monoclonal [TRAF1/2770] antibody to TRAF1.
Specificații
- Brand
- Antibodies
- Mărime
- 100µg
- Țintă
- TRAF1
- Applications
- IHC-P
- Reactivity
- Human
- Conjugate
- Unconjugated
- Host
- Mouse
- Clonality
- Monoclonal
- Product form
- Liquid
- Concentration
- 200 µg/ml
- Purification
- Protein A/G chromatography.
- Isotype
- IgG1
- Recommended dilutions
- IHC-P: 1-2 µg/ml
- Molecular weight
- 52 kDa
- Light chain
- kappa
- Clonă
- TRAF1/2770
- Imunogen
- Recombinant fragment, around amino acids 73-219, of human TRAF1 protein. The exact sequence is proprietary.
- Specificitate
- This antibody recognizes a protein of 52kDa, which is identified as TNFR1 (TNFR-associated factor 1). CD30-positive lymphoproliferations of the skin comprise 30% of all primary cutaneous T-cell lymphomas (CTCLs). Besides borderline cases this group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large T-cell lymphoma (cALCL). Although the two entities overlap clinically, histopathologically, immunopathologically and genetically, they differ considerably in their prognosis. In particular, common feature of both cases is histologically the presence of atypical lymphoid CD30-positive T blasts and genetically a clonal T-cell-receptor rearrangement. However, both cases differ considerably in their clinical course: Lesions of LyP regress spontaneously, whereas those of cALCL persist and may progress and spread. Moreover, LyP patients do not benefit from an aggressive radio- and/or chemotherapeutic approach, in contrast to patients with cALCL. Besides, LyP and cALCL differ strongly in the expression of TRAF1 (tumor necrosis factor receptor (TNFR)-associated factor 1), a component of TNFR signaling: Whereas tumor cells of most LyP cases (ca. 84%) show a strong TRAF1 expression, tumor cells of cALCL reveal TRAF1 expression in only a few cases (ca. 7%). Antibody to TRAF1 is highly useful for the differentiation of LyP and cALCL in patients with cutaneous CD30-positive lymphoproliferations.
Documentație
Produse similare
Imagine indisponibilă
Imagine indisponibilăAntibodiesA253392Anti-TRAF1 Antibody [TRAF1/2770] - BSA and Azide free
3.826,63 lei3.162,50 leiTVA inclus (21%)fără TVA
Imagine indisponibilăAntibodiesA253393Anti-TRAF1 Antibody [TRAF1/3298] - BSA and Azide free
3.826,63 lei3.162,50 leiTVA inclus (21%)fără TVA
Imagine indisponibilăAntibodiesA84189Anti-TRAF1 Antibody - Identical to Abcam (ab48002)
1.297,73 – 3.527,15 lei1.072,50 – 2.915,00 leiTVA inclus (21%)fără TVA
Imagine indisponibilăAntibodiesA60587Recombinant Human TRAF1 Protein (N-terminal His Tag)
1.963,23 – 20.663,78 lei1.622,50 – 17.077,50 leiTVA inclus (21%)fără TVA
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilăAntibodiesA250208Anti-GRP94 Antibody [HSP90B1/3168R]
3.826,63 lei3.162,50 leiTVA inclus (21%)fără TVA